Annual report pursuant to Section 13 and 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Related Party Transactions Acquisitions (Details)

v3.7.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Related Party Transactions Acquisitions (Details)
12 Months Ended
Jun. 30, 2014
USD ($)
May 02, 2014
USD ($)
installment
payment
shares
May 02, 2013
USD ($)
Dec. 31, 2016
USD ($)
Dynamic Advances, IP Liquidity and Sarif Biomedical        
Related Party Transactions        
Number of purchase agreements   3    
Dynamic Advances, IP Liquidity and Sarif Biomedical | Pay Proceeds Agreement Member | Maximum        
Related Party Transactions        
Reimbursement Revenue   $ 250,000,000    
Dynamic Advances, IP Liquidity and Sarif Biomedical | Pay Proceeds Agreement Member | $10,000,000 or less | Maximum        
Related Party Transactions        
Reimbursement Revenue   $ 10,000,000    
Dynamic Advances, IP Liquidity and Sarif Biomedical | Pay Proceeds Agreement Member | $10,000,000 to $40,000,000        
Related Party Transactions        
Net recovery proceeds due to sellers (as a percent)   40.00%    
Dynamic Advances, IP Liquidity and Sarif Biomedical | Pay Proceeds Agreement Member | $10,000,000 to $40,000,000 | Minimum        
Related Party Transactions        
Reimbursement Revenue   $ 10,000,000    
Dynamic Advances, IP Liquidity and Sarif Biomedical | Pay Proceeds Agreement Member | $10,000,000 to $40,000,000 | Maximum        
Related Party Transactions        
Reimbursement Revenue   $ 40,000,000    
Dynamic Advances, IP Liquidity and Sarif Biomedical | Pay Proceeds Agreement Member | Over $40,000,000        
Related Party Transactions        
Net recovery proceeds due to sellers (as a percent)   50.00%    
Dynamic Advances, IP Liquidity and Sarif Biomedical | Pay Proceeds Agreement Member | Over $40,000,000 | Minimum        
Related Party Transactions        
Reimbursement Revenue   $ 40,000,000    
Dynamic Advances, LLC        
Related Party Transactions        
Ownership interest held (as a percent)   100.00%    
Number of cash payments made | payment   2    
Payments to Acquire Businesses, Net of Cash Acquired     $ 5,225,000 $ 6,653,078
Maximum possible amount of future payments   $ 250,000,000    
IP Liquidity        
Related Party Transactions        
Ownership interest held (as a percent)   100.00%    
Number of cash payments made | payment   2    
Payments to Acquire Businesses, Net of Cash Acquired $ 2,850,000 $ 5,225,000    
Maximum possible amount of future payments   $ 250,000,000    
Sarif Biomedical, LLC        
Related Party Transactions        
Ownership interest held (as a percent)   100.00%    
Number of cash payments made | payment   2    
Payments to Acquire Businesses, Net of Cash Acquired   $ 550,000   $ 552,024
Maximum possible amount of future payments   $ 250,000,000    
Acquired Intellectual Property | Erich Spangenberg | Dynamic Advances, IP Liquidity and Sarif Biomedical        
Related Party Transactions        
Number of purchase agreements   3    
Acquired Intellectual Property | Erich Spangenberg | Dynamic Advances, IP Liquidity and Sarif Biomedical | Pay Proceeds Agreement Member | Maximum        
Related Party Transactions        
Reimbursement Revenue   $ 250,000,000    
Acquired Intellectual Property | Erich Spangenberg | Dynamic Advances, IP Liquidity and Sarif Biomedical | Pay Proceeds Agreement Member | $10,000,000 or less        
Related Party Transactions        
Reimbursement Revenue   $ 10,000,000    
Acquired Intellectual Property | Erich Spangenberg | Dynamic Advances, IP Liquidity and Sarif Biomedical | Pay Proceeds Agreement Member | $10,000,000 to $40,000,000        
Related Party Transactions        
Net recovery proceeds due to sellers (as a percent)   40.00%    
Acquired Intellectual Property | Erich Spangenberg | Dynamic Advances, IP Liquidity and Sarif Biomedical | Pay Proceeds Agreement Member | $10,000,000 to $40,000,000 | Minimum        
Related Party Transactions        
Reimbursement Revenue   $ 13,000,000    
Acquired Intellectual Property | Erich Spangenberg | Dynamic Advances, IP Liquidity and Sarif Biomedical | Pay Proceeds Agreement Member | $10,000,000 to $40,000,000 | Maximum        
Related Party Transactions        
Reimbursement Revenue   40,000,000    
Acquired Intellectual Property | Erich Spangenberg | Dynamic Advances, IP Liquidity and Sarif Biomedical | Pay Proceeds Agreement Member | Over $40,000,000        
Related Party Transactions        
Reimbursement Revenue   40,000,000    
Payments of Reimbursement Revenue   $ 2,400,000    
Net recovery proceeds due to sellers (as a percent)   50.00%    
Acquired Intellectual Property | Erich Spangenberg | Dynamic Advances, LLC        
Related Party Transactions        
Ownership interest held (as a percent)   100.00%    
Number of cash payments made | installment   2    
Second payment amount after June 30, 2014   $ 2,850,000    
Preferred stock, shares issued | shares   195,500    
Maximum possible amount of future payments   $ 250,000,000    
Acquired Intellectual Property | Erich Spangenberg | IP Liquidity        
Related Party Transactions        
Ownership interest held (as a percent)   100.00%    
Number of cash payments made | installment   2    
Second payment amount after June 30, 2014   $ 2,850,000    
Preferred stock, shares issued | shares   195,500    
Maximum possible amount of future payments   $ 250,000,000    
Acquired Intellectual Property | Erich Spangenberg | Sarif Biomedical, LLC        
Related Party Transactions        
Ownership interest held (as a percent)   100.00%    
Number of cash payments made | installment   2    
Payments to Acquire Businesses, Net of Cash Acquired   $ 250,000    
Second payment amount after June 30, 2014   300,000    
Maximum possible amount of future payments   $ 250,000,000